Eiko Lifesciences Ltd consolidated Q1FY26 net profit at Rs. 1.11 crore

Narendra Investments (Delhi) Ltd has reported Consolidated financial results for the period ended June 30, 2025.

Financial Results (Q1 FY2026) - QoQ Comparison

The company has reported total income of Rs. 10.9766 crores during the period ended June 30, 2025 as compared to Rs. 11.5003 crores during the period ended March 31, 2025.

The company has posted net profit / (loss) of Rs. 1.1174 crores for the period ended June 30, 2025 as against net profit / (loss) of Rs. 1.2436 crores for the period ended March 31, 2025.

The company has reported EPS of Rs. 0.66 for the period ended June 30, 2025 as compared to Rs. 0.80 for the period ended March 31, 2025.

Financials	Q1 FY2026	Q4 FY2025	% Change
Total Income	₹ 10.9766 crs	₹11.5003 crs	-4.55%
Net Profit	₹1.1174 crs	₹1.2436 crs	-10.15%
EPS	₹0.66	₹0.80	-17.50%

Financial Results (Q1 FY2026) - YoY Comparison

The company has reported total income of Rs. 10.9766 crores during the period ended June 30, 2025 as compared to Rs.11.0126 crores during the period ended June 30, 2024.

The company has posted net profit / (loss) of Rs.1.1174 crores for the period ended June 30, 2025 as against net profit / (loss) of Rs.0.3713 crores for the period ended June 30, 2024.

The company has reported EPS of Rs.0.66 for the period ended June 30, 2025 as compared to Rs.0.29 for the period ended June 30, 2024.

Financials	Q1 FY2026	Q1 FY2025	% Change
Total Income	₹ 10.9766 crs	₹11.0126 crs	-0.33%
Net Profit	₹1.1174 crs	₹0.3713 crs	200.94%
EPS	₹0.66	₹0.29	127.59%

Shares of Narendra Investments (Delhi) Ltd was last trading in BSE at Rs. 55.06 as compared to the previous close of Rs. 51.79. The total number of shares traded during the day was 32444 in over 250 trades.

The stock hit an intraday high of Rs. 58.50 and intraday low of 51.75. The net turnover during the day was Rs. 1777637.00.

Source : Equity Bulls

Keywords

EikoLifesciences Q1FY26 Q1FY2026 FY2026 ResultUpdate